Swedish Heart Lung Foundation   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Stockholm Sweden (1904)

Organization Overview

First Clinical Trial
1995
NCT00389168
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Swedish Heart Lung Foundation